NCT02768259

Brief Summary

  • Measuring the incidence and prevalence of PAH in Egyptian patients with different types of MCD
  • Determination of survival \& the risk factors of mortality.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 11, 2016

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

July 12, 2016

Status Verified

July 1, 2016

Enrollment Period

11 months

First QC Date

May 8, 2016

Last Update Submit

July 11, 2016

Conditions

Connective Tissue DiseasesPulmonary Hypertension

Outcome Measures

Primary Outcomes (1)

  • prevalence

    Pulmonary hypertension

    1 year

Secondary Outcomes (1)

  • Survival

    1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients diagnosed as connective tissue diseases fulfilling ACR criteria will be recruited

You may qualify if:

  • \- Patients diagnosed as connective tissue diseases fulfilling ACR criteria will be recruited

You may not qualify if:

  • non

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Alaini School of Medicine

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Connective Tissue DiseasesHypertension, Pulmonary

Condition Hierarchy (Ancestors)

Skin and Connective Tissue DiseasesLung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Mostafa I Elshazly, MD

    Professor of pulmonary Medicine ,Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mostafa I Elshazly, MD

CONTACT

00201001272020elshazly66@hotmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of pulmonary Medicine

Study Record Dates

First Submitted

May 8, 2016

First Posted

May 11, 2016

Study Start

June 1, 2016

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

July 12, 2016

Record last verified: 2016-07

Locations

EG(1)